ONWD — Onward Medical NV Cashflow Statement
0.000.00%
Last trade - 00:00- €181.19m
- €126.74m
- €3.78m
Annual cashflow statement for Onward Medical NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -34.2 | -33.5 | -36.1 | -35.8 | -41.5 |
| Depreciation | |||||
| Non-Cash Items | 14.5 | 3.46 | 3.45 | 3.89 | 3.4 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.437 | 2.66 | -0.37 | -0.787 | -2.43 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -19.9 | -26.7 | -32.3 | -31.8 | -39.1 |
| Capital Expenditures | -2.32 | -0.417 | -0.422 | -0.15 | -0.432 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -20 | 20 | 0 | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -2.32 | -20.4 | 19.6 | -0.15 | -0.432 |
| Financing Cash Flow Items | -4.6 | — | — | -5.74 | -3.24 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 105 | -0.557 | 0.813 | 62.6 | 47.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 83.1 | -47.7 | -12 | 30.3 | 8.07 |